← Back
$ETON All transactions

Eton Pharmaceuticals, Inc.

F

$ Value

$106K

Shares

6,264

Price

$17

Filed

Dec 12

Insider

Name

Krempa David

Title

Chief Business Officer

CIK

0001968254

Roles

Officer

Transaction Details

Transaction Date

2025-12-12

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

632,180

Footnotes

Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units. | The shares were sold in multiple trades at prices ranging from $16.83 to $17.11. The price reported above reflects the weighted average sales price. | The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. | Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock. | The restricted stock units vest immediately as of the award date.

Filing Info

Accession No.

0001437749-25-037745

Form Type

4

Issuer CIK

0001710340

Krempa David's History

Date Ticker Type Value
2026-01-14 ETON F $30K
2026-01-12 ETON A $0
2026-01-12 ETON A $0
2025-12-12 ETON F $106K
2025-12-11 ETON A $0
2025-06-16 ETON $151K
2025-06-13 ETON $100K
2025-06-12 ETON $253K

Other Insiders at ETON (90d)

Insider Bought Sold Last
RIEDEL NORBERT G 2026-04-21